Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Jun 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
79961401000001111 | Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
79961501000001110 | Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | Has VMP | Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges | true | Inferred relationship | Existential restriction modifier | ||
Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | Has specific active ingredient | Prilocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | Has specific active ingredient | Felypressin | true | Inferred relationship | Existential restriction modifier | ||
Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Citanest 3% with Octapressin Dental 0.066units/2.2ml solution for injection self aspirating cartridges (Dentsply Ltd) 100 cartridge | Is a | True | Prilocaine 66mg/2.2ml / Felypressin 0.066units/2.2ml solution for injection self aspirating cartridges 100 cartridge | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets